{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-23-001206","form_type":"8-K","ticker":"AXIM","cik":"0001514946","company_name":"AXIM BIOTECHNOLOGIES, INC.","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.187057+00:00","generated_at":"2026-06-14T11:37:43.015771+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AXIM Biotechnologies issues $575K in convertible notes with 3.75% interest and variable conversion price","bullets":["Aggregate principal of $575,000: $325,000 cash from four notes, $250,000 to repay prior advances.","Interest rate 3.75% per annum, payable annually starting May 23, 2024; maturity May 23, 2033.","Conversion price is lesser of $0.01 or 70% of average of two lowest closing prices in prior 10 trading days.","Notes are unsecured; no prepayment without holder consent; includes 4.9% beneficial ownership blocker.","Event of default allows holder to accelerate all principal and accrued interest."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-23-001206","json":"https://secwatch.observer/filing/0001096906-23-001206.json","markdown":"https://secwatch.observer/filing/0001096906-23-001206.md","text":"https://secwatch.observer/filing/0001096906-23-001206.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623001206/0001096906-23-001206-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623001206/axim-20230523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T11:37:43.015771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14ab6376b632a5548142a033d338727f472bdf55","claim":"AXIM BIOTECHNOLOGIES, INC. incurred convertible notes of $575,000 with certain investors at 3.75% per annum maturing May 23, 2033.","evidence_excerpt":"On May 23, 2023, AXIM Biotechnologies, Inc. (the “Company”) issued five (5) convertible promissory notes in the aggregate principal amount of $575,000 (the \"Convertible Notes\") to certain investors.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623001206/0001096906-23-001206-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$575,000"},{"label":"Counterparty","value":"certain investors"},{"label":"Rate","value":"3.75% per annum"},{"label":"Maturity","value":"May 23, 2033"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}